Advertisement

Arterial Wall Characteristics in Patients with Adamantiades-Behçet’s Disease

  • A. Protogerou
  • J. Lekakis
  • K. Stamatelopoulos
  • K. Aznaouridis
  • E. Karatzis
  • I. Ikonomidis
  • Ch. Papamichael
  • N. Markomihelakis
  • M. Mavrikakis
  • Ph. G. Kaklamanis
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 528)

Conclusions

Endothelial vasomotor dysfunction was observed in patients with ABD in both active and inactive stages of the disease, thus brachial artery flow-mediated dilation test seems unable to detect activity of the disease. No sign of peripheral atherosclerosis as assessed by IMT was observed in our study group. Arterial stiffness was reduced in patients with active disease, and AI could be useful in the future for detecting ABD activity; more studies are needed on this issue. Our study is being continued in order to increase the number of our study objects and validate the use of AI and FMD for the control of the activity of ABD, and prediction of vascular complications, respectively.

Keywords

Nitric Oxide Arterial Stiffness Brachial Artery Vascular Complication Augmentation Index 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Koc, Y., Gullu, I., Akpek, G., et al, 1992, Vascular involvement in Behçet’s disease. J. Rheumatol. 19: 402.PubMedGoogle Scholar
  2. 2.
    Sakane, T., Takeno, M., Suzuki, N., et al., 1999, Behçet’s disease. N. Engl. J. Med. 341: 1248–1291.CrossRefGoogle Scholar
  3. 3.
    Kaklamani, V.G., Vaiopoulos, G., and Kaklamanis, P.G., 1998, Behçet’s disease. Semin. Arthritis Rheum. 27: 197–217.CrossRefPubMedGoogle Scholar
  4. 4.
    Chambers, J., Haskard, D., and Kooner, J., 2001, Vascular endothelial function and oxidative stress mechanisims in patients with Behçet syndrome. J. Am. Coll. Cardiol. 37: 517–520.CrossRefPubMedGoogle Scholar
  5. 5.
    International Study Group for Behçet’s disease, 1990, Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078–1080.Google Scholar
  6. 6.
    Celermajer, D.S., Sörensen, K.E., Gooch, V.M. et al., 1992, Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111–1115.CrossRefPubMedGoogle Scholar
  7. 7.
    Anderson, E.A., and Mark, A.L., 1989, Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 79: 93–100.PubMedGoogle Scholar
  8. 8.
    O’Rourk, M.F., and Gallagher, D.E., 1996, Pulse wave analysis. J. Hypertens. 14(suppl. 5): S147–S157.Google Scholar
  9. 9.
    Chen, C.H., Nevis, E., Fectis, B., et al., 1999, Estimation of central pressure waveform by mathematical trasnformation of radial tonometry. Circulation 95: 1827–1836.Google Scholar
  10. 10.
    Lekakis, J.P., Papamichael, Ch., Cimponeriu, A., et al., 2000, Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Am. J. Cardiol. 85: 949–952.CrossRefPubMedGoogle Scholar
  11. 11.
    Salonen, J.T., and Salonen, R., 1993, Ultrasonographically assesed carotid morphology and the risk of coronary heart disease. Arterioscler. Thromb. 13: 1404–1411.Google Scholar
  12. 12.
    Orem, A., Vanizor, B., Cismir, G., et al., 1999, Decreased nitricoxide production in patients with Behçet’s disease. Dermatology 198: 33–36.PubMedGoogle Scholar
  13. 13.
    Lekakis, J., Mavrikakis, M., Papamichael, Ch., et al., 1998, Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud’s phenomenon. Am. Heart J. 136: 905–912.CrossRefPubMedGoogle Scholar
  14. 14.
    Everklioglu, C., Turkoz, Y., Er, H., et al., 2002, Increased nitric oxide production in patients with Behçet’s disease: is it a new activity marker. J. Am. Acad. Dermatol. 46: 50–54.Google Scholar
  15. 15.
    Kiraz, S., Esrtenli, I., Calguneri, M., et al., 2002, Interactions of nitric oxide and superoxide didmutase in Behçet’s disease. Clin. Exp. Rheumtol. 19: S25–29.Google Scholar
  16. 16.
    Beckman, J.S., and Koppenol, W.H., 1996, Ntric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271: C1424–C1437.PubMedGoogle Scholar
  17. 17.
    Cooke, J.P., and Creager, M.A., 2000, Hypercholesterolemia, atherosclerosis, and the NO synthase pathway. In Vascular endothelium in human physiology and pathophysiology, (P.J.T. Vallance, and D.J. Webb, eds.), Harwood Academic Publishers, New York, p. 147Google Scholar
  18. 18.
    Özoran, K., Dugan, N., Görler, A., et al., 1992, Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet’s disease. Scand. J. Reumatol. 24: 376–382.Google Scholar
  19. Hampton, K.K., Chamberlain, M.A., Menon, D.K., et al., 1991, Coagulation and fibrinolytic activity in Behçet’s disease. Thromb. Heamost. 66:292–294.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • A. Protogerou
    • 1
  • J. Lekakis
    • 1
  • K. Stamatelopoulos
    • 1
  • K. Aznaouridis
    • 1
  • E. Karatzis
    • 1
  • I. Ikonomidis
    • 1
  • Ch. Papamichael
    • 1
  • N. Markomihelakis
    • 2
  • M. Mavrikakis
    • 1
  • Ph. G. Kaklamanis
    • 2
  1. 1.Alexandra University HospitalNational University of AthensAthensGreece
  2. 2.Medical CenterAthensGreece

Personalised recommendations